Prebiotic oligosaccharides in dietetic products for infants: A commentary by the espghan committee on nutrition

Journal of Pediatric Gastroenterology and Nutrition

Volumn 39, Issue 5, 2004, Pages 465-473

  Agostoni, Carlo ^a   Axelsson, Irene ^a   Goulet, Olivier ^a   Koletzko, Berthold ^a   Michaelsen, Kim F ^a   Puntis, John W L ^b   Rigo, Jacques ^b   Shamir, Raanan ^c   Szajewska, Hania ^c   Turck, Dominique ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b LUND UNIVERSITY   (Sweden)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Infant formula; Infant nutrition; Prebiotics

Indexed keywords

OLIGOSACCHARIDE; PROBIOTIC AGENT;

ARTICLE; ARTIFICIAL MILK; BABY FOOD; BIFIDOBACTERIUM; FECES; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFANT; MICROBIOLOGY; NEWBORN; PREMATURITY; SAFETY; TREATMENT OUTCOME;

BIFIDOBACTERIUM; CONSUMER PRODUCT SAFETY; FECES; GASTROINTESTINAL TRACT; HUMANS; INFANT; INFANT FOOD; INFANT FORMULA; INFANT, NEWBORN; INFANT, PREMATURE; OLIGOSACCHARIDES; PROBIOTICS; TREATMENT OUTCOME;

EID: 20144387171     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/00005176-200411000-00003     Document Type: Article

References (64)

1. ESPGHAN Committee on Nutrition. Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2004;38:365-74.
2. ESPGHAN Committee on Nutrition. Nondigestible carbohydrates in the diets of infants and young children: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2003;36:329-37.
3. Rotimi VO, Duerden B. The development of the bacterial flora in normal neonates. J Med Microbiol 1981;14:51-62.
4. Brook I, Barrett CT, Brinkman CR 3rd, et al. Aerobic and anaerobic bacterial flora of the maternal cervix and newborn gastric fluid and conjunctiva: a prospective study. Pediatrics 1979;63:451-5.
5. Tannock GW, Fuller R, Smith SL, et al. Plasmid profiling of members of the family Enterobacteriaceae, lactobacilli, and bifidobacteria to study the transmission of bacteria from mother to infant. J Clin Microbiol 1990;28:1225-8.
6. Long SS, Swenson RM. Development of anaerobic fecal flora in healthy newborn infants. J Pediatr 1977;91:298-301.
7. Satokari RM, Vaughan EE, Favier CF, et al. Diversity of Bifidobacterium and Lactobacillus spp. in breast-fed and formula-fed infants as assessed by 16S rDNA sequence differences. Microb Health Dis 2002;14:97-105.
8. Orrhage K, Nord CE. Factors controlling the bacterial colonization of the intestine in breast-fed infants. Acta Paediatr Suppl 1999;430:47-57.
9. Benno Y, Sawada K, Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 1984;28:975-86.
10. Lunderquist B, Nord CE, Winberg J. The composition of the faecal microflora in breast-fed and bottle-fed infants from birth to eight weeks. Acta Paediatr Scand 1985;74:45-51.
11. Mevissen-Verhage EA, Marcelis JH, de Vos MN, et al. Bifidobacterium, Bacteroides, and Clostridium spp. in fecal samples from breast-fed and bottle-fed infants with and without iron supplementation. J Clin Microbiol 1987;25:285-9.
12. Mata LV, Urrutia JJ. Intestinal colonization of breast-fed children in a rural area of low socio-economic level. Ann N Y Acad Sci 1971;176:93-109.
13. Stark PL, Lee A. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol 1982;15:189-203.
14. Howie PW. Protective effect of breastfeeding against infection in the first and second six months of life. Adv Exp Med Biol 2002;503:141-7.
15. Howie PW, Forsyth JS, Ogston SA. Protective effect of breast feeding against infection. Br Med J 1990;300:11-6.
16. Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding (Cochrane Review). The Cochrane Library 2003, Issue 3.
17. Kelleher SL, Casas I, Carbajal N, et al. Supplementation of infant formula with the probiotic Lactobacillus reuteri and zinc: impact on enteric infection and nutrition in infant rhesus monkeys. J Pediatr Gastroenterol Nutr 2002;35:162-8.
18. Sudo N, Sawamura S, Tanaka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739-45.
19. Heine WE, Mohr C, Wutzke KD. Host-microflora correlations in infant nutrition. Prog Food Nutr Sci 1992;16:181-97.
20. Radke M, Mohr C, Wutzke KD, HeineW. Phosphate concentration: does reduction in infant formula feeding modify the micro-ecology of the intestine? [in German]. Monatsschr Kinderheilkd 1992;140(Suppl 1):S40-4.
21. Bullen JJ, Rogers HJ, Leigh L. Iron-binding proteins in milk and resistance to Escherichia coli infections in infants. Br Med J 1972;1:69-75
22. Gil A, Corral E, Martinez A, et al. Effects of the addition of nucleotides to an adapted milk formula on the microbial pattern of faeces in term infants. J Clin Nutr Gastroenterol 1986;1:127-32.
23. Kunz C, Rodriguez M, Koletzko B, et al. Nutritional and biochemical properties of human milk, part I. General aspects, proteins and carbohydrates. Clin Perinatol 1999;26:307-33.
24. Kunz C, Rudloff S, BaierW, et al. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Ann Rev Nutr 2000;20:699-722.
25. Engfer MB, Stahl B, Finke B, et al. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr 2000;71:1589-96.
26. Erney RM, Malone WT, Skelding MB, et al. Variability of human milk neutral oligosaccharides in a diverse population. J Pediatr Gastroenterol Nutr 2000;30:131-3.
27. Crittenden RG. Prebiotics. In: Tannock GW, ed. Probiotics: A Critical Review. Wymondham: Horizon Scientific Press, 1999:141-156.
28. Fuller R. Probiotics in human medicine. Gut 1991;32:489-92.
29. Bellisle R, Diplock AT, Hornstra G, et al. Functional food science in Europe. Br J Nutr 1998;80(Suppl):S3-193.
30. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microflora: introducing the concept of prebiotics. J Nutr 1995;125:1401-12.
31. Macfarlane GT, Cummings JH. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? Br Med J 1999;318:999-1003.
32. Favier CF, Vaughan EE, De Vos WM, et al. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environm Microbiol 2002;68:219-26.
33. Favier CF, De Vos WM, Akkermans ADL. Development of bacterial and bifidobacterial communities in feces of newborn infants. Anaerobe 2003;9:219-29.
34. Van Loo J, Cummings J, et al. Functional food properties on nondigestible oligosaccharides: a consensus report from the ENDO project (DGXII-AIRII-CT94-1095). Br J Nutr 1999;81:121-32.
35. Szilagyi A. Review article: lactose-a potential prebiotic. Aliment Pharmacol Ther 2002;16:1591-602.
36. Playne MJ, Crittenden R. Commercially available oligosaccharides. Bulletin of the International Dairy Federation 1996;313:10-22.
37. Hopkins MJ, Cummings JH, Macfarlane GT. Interspecies differences in maximum specific growth rates and cell yields of bifidobacteria cultured on oligosaccharides and other simple carbon sources. J Appl Microbiol 1998;85:381-6.
38. Rastall RA, Gibson GR. Prebiotic oligosaccharides: evaluation of biologic activities and potential future developments. In: Tannock GW, ed. Probiotics and Prebiotics: Where Are We Going? Wymondham: Caister Academic Press, 2002:108-48.
39. Van Loo J, Cummings J, Delzenne N, et al. Functional food properties on non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095). Br J Nutr 1999;81:121-32.
40. ESPGHAN Committee on Nutrition. Core data for nutrition trials in infants: a discussion document-a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2003;36:338-42.
41. ESPGHAN Committee on Nutrition. The nutritional and safety assessment of breast milk substitutes and other dietary products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2001;32:256-8.
42. Scientific Committee on Food. Report of the Scientific Committee on Food on the revision of essential requirements of infant formula and follow-up formula (adopted on 4 April 2003). SCF/CS/NUT/IF/65 Final 18 May 2003.
43. Gay-Crosier F, Schreiber G, Hauser C. Anaphylaxis from inulin in vegetables and processed food. N Engl J Med 2000;18:1372-3.
44. AFSSA (Agence Franaise de Sècuritè Sanitaire des Aliments-French Food Safety Agency). Infant food and modification of intestinal flora (working document) [in French]. 2003. Available at:.
45. Moro G, Minoli I, Mosca M, et al. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr 2002;34:291-5.
46. Boehm G, Lidestri M, Casetta P, et al. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of fecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed 2002;86:F178-81.
47. Schmelzle H, Wirth S, Skopnik H, et al. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr 2003;36:343-51.
48. Fusch C, Skopnik H, Wirth S, et al. Double-blind, randomized, placebo-controlled study to evaluate the nutritional efficacy of Omneo 1. Final study results. Pediatrika 2001;21:49-54.
49. Alarcon PA, Tressler RL, Mulvaney A, et al. Gastrointestinal tolerance of a new infant milk formula in healthy babies: an international study conducted in 17 countries. Nutrition 2002;18:484-9.
50. Yamamoto Y, Yonekubo A. A survey of physical growth, nutritional intake, fecal properties and morbidity of infants related to feeding methods. Shoni Hoken Kenkya 1993;52:465-71.
51. Blakey JL, Lutitz L, Barnes GL, et al. Development of gut colonisation in preterm neonates. J Med Microbiol 1982;15:519-29.
52. Gewold IH, Schwalbe RS, Taciak VL, et al. Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1999;80:F167-73.
53. Koletzko B, Ashwell M, Beck B, et al. Characterisation of infant food modifications in the European Union. Ann Nutr Metab 2002;46:231-42.
54. American Academy of Pediatrics. Clinical Testing of Infant Formulae With Respect to Nutritional Suitability for Term Infants. Report of AAP Task Force. Rosemont, IL: American Academy of Pediatrics; 1989.
55. Duggan C, Penny ME, Hibberd P, et al. Oligofructose-supplemented infant cereal: two randomized, blinded, community-based trials in Peruvian infants. Am J Clin Nutr 2003;77:937-42.
56. Moore N, Chao C, Yang LP, et al. Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial. BR J Nutr 2003;90:581-7.
57. Hoekstra JH, Szajewska H, Abu Zikri M, et a. Oral rehydration solution containing a mixture of nondigestible carbohydrates in the treatment of acute diarrhea: a multicenter randomized placebo controlled study on behalf of the ESPGHAN Working Group on Intestinal Infections. J Pediatr Gastroenterol Nutr 2004;39:239-45.
58. Griffin IJ, Davila PM, Abrams SA. Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes. Br J Nutr 2002;87:S187-91.
59. Van den Heuvel EG, Muys T, van Dokkum W, et al. Oligofructose stimulates calcium absorption in adolescents. Am J Clin Nutr 1999;69:544-8.
60. Conway PL. Prebiotics and human health: the state-of-the-art and future perspectives. Scand J Nutr 2001;45:13-21.
61. Andersson H, Asp N-H, Bruce (), et al. Health effects of probiotics and prebiotics: a literature review on human studies. Scand J Nutr 2001;45:58-75.
62. Safety evaluation of fructans. Nordic Council of Ministers, Copenhagen 2000. TemaNord 2000;523:115.
63. Van Leeuwen PA, Boermeester MA, Houdijk AP, et al. Clinical significance of translocation. Gut 1994;35(Suppl):S28-34.
64. Bovee-Oudenhoven IMJ, ten Bruggencate SJM, Lettink-Wissink MLG, et al. Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of Salmonella in rats. Gut 2003;52:1572-8.